Evidera
Evidera is a global leader in health economics, market access, and clinical research solutions. They support clients with regulatory and HTA methods, real-world evidence, patient-centered research, and post-market safety studies. Their expertise spans across multiple therapeutic areas and they collaborate with regulatory bodies and payers worldwide to optimize product development and market access. Evidera's mission is to transform data into actionable insights, helping bring life-changing treatments to patients faster and more efficiently.
Industries
Nr. of Employees
large (251-1000)
Evidera
1001 Fannin Street, Houston, TX 77002, USA
Products
Central laboratory data portal
A centralized portal for laboratory data exchange and visualization to support chain-of-custody, reporting and study timelines for central lab operations.
Clinical decision and forecasting analytics suite
Integrated analytics platforms for clinical decision support, trial forecasting and study performance monitoring using predictive models and historical trial data.
Interactive value communication platform
Secure, web-hosted platform for housing and presenting value communication materials, enabling dynamic slide presentations, interactive economic model visualization and extraction of country-specific dossier content.
Central laboratory data portal
A centralized portal for laboratory data exchange and visualization to support chain-of-custody, reporting and study timelines for central lab operations.
Clinical decision and forecasting analytics suite
Integrated analytics platforms for clinical decision support, trial forecasting and study performance monitoring using predictive models and historical trial data.
Interactive value communication platform
Secure, web-hosted platform for housing and presenting value communication materials, enabling dynamic slide presentations, interactive economic model visualization and extraction of country-specific dossier content.
Services
Early-through-late phase clinical development strategy, protocol design, adaptive design consultation and integrated regulatory and biostatistical input.
Design and execution of observational studies, disease registries, external control arms and real-world analyses to support safety, effectiveness and market access.
Validated assay development and execution, central lab sample processing (including PBMC), chain-of-custody management, and GMP laboratory analytics such as LC-MS and rapid microbiology testing.
Health economic modeling, payer evidence plans, HTA strategy and pricing/reimbursement support across global markets.
Provision of outsourced functional teams (for example, clinical operations, data management, pharmacovigilance) with capacity management and hybrid onsite/remote models.
Deployment of clinical decision analytics, trial forecasting and intelligent clinical platforms that apply data science and AI to trial planning and performance monitoring.
Early-through-late phase clinical development strategy, protocol design, adaptive design consultation and integrated regulatory and biostatistical input.
Design and execution of observational studies, disease registries, external control arms and real-world analyses to support safety, effectiveness and market access.
Validated assay development and execution, central lab sample processing (including PBMC), chain-of-custody management, and GMP laboratory analytics such as LC-MS and rapid microbiology testing.
Health economic modeling, payer evidence plans, HTA strategy and pricing/reimbursement support across global markets.
Provision of outsourced functional teams (for example, clinical operations, data management, pharmacovigilance) with capacity management and hybrid onsite/remote models.
Deployment of clinical decision analytics, trial forecasting and intelligent clinical platforms that apply data science and AI to trial planning and performance monitoring.
Expertise Areas
- Clinical trial management
- Adaptive trial design and Bayesian statistics
- Biostatistics and clinical data science
- Real-world evidence and registry studies
Key Technologies
- eCOA and electronic patient-reported outcome implementation
- Decentralized clinical trial platforms
- Adaptive trial simulation and Bayesian methods
- LC-MS bioanalytical methods
News & Updates
CADTH has launched new parallel scientific advice programs with NICE and Health Canada, allowing manufacturers to confirm a single approach for evidence generation that meets the needs of both organizations.
A webinar discussing the need for post-approval research to understand product safety in pregnant women, using COVID-19 vaccines as an example.
Evidera collaborated with Takeda and The Leukemia & Lymphoma Society on a study of patient preferences for Ph+ALL treatments, which was recognized in the PFMD Book of Good Practices.
CADTH has launched new parallel scientific advice programs with NICE and Health Canada, allowing manufacturers to confirm a single approach for evidence generation that meets the needs of both organizations.
A webinar discussing the need for post-approval research to understand product safety in pregnant women, using COVID-19 vaccines as an example.
Evidera collaborated with Takeda and The Leukemia & Lymphoma Society on a study of patient preferences for Ph+ALL treatments, which was recognized in the PFMD Book of Good Practices.